Kolexia
Borentain Patrick
Gastro-entérologie
Hôpital La Conception
Marseille, France
117 Activités
30 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite E Cirrhose du foie Carcinome hépatocellulaire Hépatite B Hépatite C Carcinomes Tumeurs du foie Hypertension portale

Industries

IQVIA
54 collaboration(s)
Dernière en 2023
B3TSI
46 collaboration(s)
Dernière en 2023
A+A
42 collaboration(s)
Dernière en 2023
Genactis SAS
9 collaboration(s)
Dernière en 2021

Dernières activités

Liver transplantation due to fulminant hepatitis a in a traveller visiting friends and relatives in Comoros.
Journal of travel medicine   11 décembre 2023
Increased fecal ethanol and enriched ethanol-producing gut bacteria , , and in nonalcoholic steatohepatitis.
Frontiers in cellular and infection microbiology   16 novembre 2023
Ethanol-Producing Is Enriched in Chronic Hepatitis B-Associated Gut Dysbiosis: A Case-Control Culturomics Study.
Microorganisms   28 septembre 2023
Limosilactobacillus fermentum, Lactococcus lactis and Thomasclavelia ramosa are enriched and Methanobrevibacter smithii is depleted in patients with non-alcoholic steatohepatitis.
Microbial pathogenesis   20 mai 2023
Endogenous Ethanol and Triglyceride Production by Gut , and Yeasts in Non-Alcoholic Steatohepatitis.
Cells   27 octobre 2022
Bulevirtide 2mg-based real-life treatment of hepatitis Delta with genotypes 1 and 5 viruses at more than 20 months of follow-up.
Clinics and research in hepatology and gastroenterology   20 octobre 2022
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
Annals of internal medicine   02 février 2021
Hepatitis B Virus Genomics Knocking at the Door of Routine Diagnostic Laboratories.
The Journal of infectious diseases   11 novembre 2020
Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestation.
Clinical rheumatology   21 septembre 2020
PRPET: Double Blind Randomized Study, Comparing Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
Essai Clinique (CHU Toulouse)   21 avril 2020